Apollo Hospitals Enterprise Ltd. Share Price

Markets Decline as Inflation and Crude Pressure Sentiment

Indian equity markets ended lower today, November 13, 2026, as rising crude oil prices and concerns over accelerating inflation weighed on investor sentiment. The Nifty 50 declined 155.05 points (0.61%) to close at 25,144.30, while the Sensex fell 318.56 points (0.39%) to settle at 81,592.45. Top Gainer : Nifty 50: APOLLOHOSP was among the leading gainers, supported by buying interest in healthcare stocks. Top Loser : Nifty 50: Shriram Finance was among the weakest performers, reflecting pressure on financial stocks. What drove the market? • Inflation concerns: India's October retail inflation rose to 6.09%, exceeding the RBI's upper tolerance limit of 6%. • Elevated crude prices: Rising oil prices increased concerns about India's import bill and inflationary pressures. • Financial stocks weakened: Banking and financial services stocks were among the major drags on the indices. • Foreign inflows offered support: Foreign investors continued buying Indian equities, providing some cushion against the broader selling pressure. Professional opinion: The decline reflects growing macroeconomic concerns, particularly the combination of elevated crude prices and inflation crossing the RBI's tolerance band. Although foreign institutional buying remains supportive, sustained inflation could limit the market's upside and put pressure on rate-sensitive sectors. The market's ability to stabilise will depend on crude price movements, inflation trends and continued institutional participation.

Apollo hospitals net profit rises 32 percent in Q2

Apollo Hospitals Enterprise Limited APOLLOHOSP reported a consolidated net profit of Rs 630 crore for the second quarter, marking a 32 percent year-on-year increase. Consolidated revenue grew 23 percent to Rs 7,615 crore, supported by broad-based expansions across hospitals, diagnostics, and digital healthcare. The hospital business drove revenue up by 23 percent to Rs 3,567 crore, helped by 14 percent volume growth and an occupancy rate of 73 percent. However, segment EBITDA margin dipped 60 basis points to 24 percent due to pre-operative expenses from new, loss-making facilities. Meanwhile, Apollo Health and Lifestyle Limited posted a net profit of Rs 18 crore, reversing a net loss from the previous year, with diagnostics emerging as a primary growth driver. Apollo HealthCo expanded revenue by 23 percent, and the digital arm, Apollo 24/7, turned cash positive for the first time. While operational metrics remain robust, the near-term outlook faces friction. The upcoming demerger of the omni-channel pharmacy and digital health business, scheduled for Q4FY27, alongside recent divestments, creates valuation uncertainty. Investors are currently weighing standalone asset values against the broader corporate structure, causing a near-term stock overhang despite strong underlying performance. The stock currently trades at 26x FY27e EV/EBITDA. Investors should monitor execution on the targeted 13,800 bed capacity by FY31 alongside the progress of the pharmacy demerger.

Nifty Outlook for 06-Nov-2026 looks Bullish

The Daily MACD Histogram is above zero and the Hourly MACD Histogram is also above zero indicating a bullish trend. The Daily RSI 14 is in the overbought territory above the 70 levels at 74.69 and the Hourly RSI 14 is also in the overbought territory above the 70 levels at 86.01 also indicates a bullish trend. But as it is in the overbought zone in both daily and hourly RSI 14. We may see a consolidation or a correction. Thus, the overall trend of Nifty looks bullish, and the buyers are in control over the markets. Buy on dips would be the best strategy to deploy for today’s market considering the overall trend of Nifty. We may expect a change in trend only if the price sustains below the support level. Can Initiate selling only if prices continue to sustain below the support level. I have provided Nifty Spot resistance and support levels which would help you learn in taking informed trading decisions using these levels and understand how support and resistance levels work in financial markets. Nifty Spot Resistance 1 - 24705 Resistance 2 - 24745 Support 1 - 24385 Support 2 - 24350 Happy Learning, Happy Trading and have a wonderful day Top Gainers : BAJFINANCE, SHRIRAMFIN, M&M. Top Losers : APOLLOHOSP, ONGC, NTPC. BAJFINANCE

Apollo Hospitals –Technical Analysis, Support and Resistance

The stock APOLLOHOSP is showing a volatile trend after facing selling pressure near the ₹9000–9050 zone. The stock recently declined towards ₹7500–7600 and then recovered sharply. It is currently trading at ₹8371 down 2.66% in the latest session, indicating selling pressure near the ₹8600–8700 zone. Support & Resistance: Immediate support is around ₹8250–8200. Below this the next support zone is ₹8000–7800. On the upside ₹8600–8700 is the immediate resistance area followed by ₹8850–9000. Short-Term Buyers & Holders View: Fresh buying may be considered after a sustained close above ₹8700 with strong volume. Existing holders should monitor the ₹8200 support zone. A breakdown below this level may lead to further correction.

Apollo Hospitals reports 32% quarterly profit growth

Apollo Hospitals Enterprise APOLLOHOSP reported approximately 32% year-on-year growth in net profit to ₹660 crore for the September 2026 quarter, supported by expansion across its healthcare operations. Revenue increased approximately 21% to ₹7,615 crore, reflecting continued business growth across the company's healthcare services portfolio. India's increasing healthcare expenditure and demand for quality medical services could support long-term expansion. However, profitability will depend on hospital occupancy, treatment volumes, operating expenses and capital expenditure. What I'm watching: Hospital occupancy, patient volumes, healthcare revenue growth, operating margins and capacity expansion. Stance: Healthy quarterly earnings and revenue growth; operational efficiency and sustainable profitability remain key factors to assess. Disclosure: This post is for educational purposes only and is not investment advice or a buy/sell recommendation. Disclose any holding or interest before publishing.

Apollo Hospitals Q2 profit rises 33.5% to Rs 659.5 crore

Apollo Hospitals Enterprise reported a 33.5% rise in Q2 profit, and the daily chart shows the stock recovering from an 18% correction. Apollo Hospitals Enterprise Limited [ APOLLOHOSP] reported Q2 consolidated profit of Rs 659.5 crore, up 33.5% from Rs 494 crore a year ago. Revenue rose 23% to Rs 7,614.9 crore from Rs 6,188.8 crore. The stock may stay in focus today, 5 November 2026, after the previous session closed with a gain of over 3%. On the daily chart, the stock fell nearly 18% from the 22 September high to the 24 October low. The fall stopped near the rising trendline drawn from 2023, and the price has since recovered most of the loss. The long-term pattern of higher highs and higher lows is still intact. The price has moved back above the 100-day SMA near 8,590. RSI near 63 shows improving momentum without an overbought reading. What next: Immediate support is placed near 8,000, and 7,465 remains the key level for the larger structure. On the upside, 9,071 is the key resistance. A close above it may confirm a fresh breakout. Failure near that zone may keep the stock in a range. Conclusion: The structure remains positive, with results adding support. Reaction near 9,071 may decide the next phase. Disclaimer: I, Akhilesh Jat (SEBI RA Reg. No. INH000016649), do not hold any position in the stock discussed. This content is informational, not a recommendation. Investments in securities are subject to market risks. Read all related documents carefully before investing.